Walleye Trading’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Walleye Trading’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,830	Closed	-$1.83K	–	4791
2024 Q3	$1.83K	Hold	25,830	–	–	﹤0.01%	3929
2024 Q2	$2.56K	Hold	25,830	–	–	﹤0.01%	4041
2024 Q1	$4.13K	Hold	25,830	–	–	﹤0.01%	4452
2023 Q4	$2.09K	Buy	+25,830	New	+$3.48K	﹤0.01%	4818

Other funds holding NKGNW

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Walleye Trading's NKGNW Position: Q4 2024 in Review

Walleye Trading sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q4 2024, closing a stake of 25,830 shares — an estimated $1.83K sold.

Walleye Trading first reported a position in NKGNW in Q4 2023 and held it in 4 quarters. The position peaked at $4.13K in Q1 2024. 26 funds tracked by Wall St. Rank hold NKGNW as of Q4 2024.

Walleye Trading reported no remaining NKGen Biotech, Inc. Warrants position as of Q4 2024 after selling out during the quarter.
Walleye Trading sold 25,830 NKGen Biotech, Inc. Warrants shares in Q4 2024, an estimated $1.83K.
Walleye Trading first reported a position in NKGen Biotech, Inc. Warrants in Q4 2023 and held it in 4 quarters.
Walleye Trading's NKGen Biotech, Inc. Warrants position peaked at $4.13K in Q1 2024.
26 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q4 2024.

Based on Walleye Trading's 13F filing for Q4 2024, filed 13 Feb 2025.